Pharma Business Daily
Claim your FREE trial subscription!


Pharmaceutical:

Pharmaceutical Growth Opportunities in Brazil, Russia, India and China:

Business Insights
Market Briefing  August 2006

Single-user PDF - USD 2875.00  


Table of Contents

Pharmaceutical Growth Opportunities in Brazil, Russia, India and China: Healthcare reform, market dynamics and key players

 



Positive economic growth, stabilizing political structures, growing patient populations and increasing direct foreign investment in the emerging markets of Brazil, Russia, India and China (BRIC) are creating significant opportunities for pharmaceutical companies to expand into these markets and maximize future revenue potential. Pharmaceutical sales across the BRIC economies grew by 22.3%in 2005, compared to single digit growth in the major markets of the US, Europe and Japan. This new report provides an in-depth insight into the competitive dynamics of the BRIC markets. The political and regulatory environments are evaluated and healthcare systems assessed, enabling you to understand the determinants crucial to your success in these high growth markets. Benchmark your growth strategies against the top pharmaceutical companies operating in the BRIC markets, align your portfolio with future market opportunity and identify lucrative partnering opportunities to ensure you maximize the potential from these promising markets.



For full details, please email jenniferc@cmsinfo.com

Order Form




CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel:     +44 (0)1494 771734
Fax:   +44 (0)1494 778994
e-mail: Jennifer Cowlard
copyright © 2008 all rights reserved

For more information about us, visit CMSinfo.

footer bar